As of 2024-12-12, the EV/EBITDA ratio of Britannia Life Sciences Inc (BLAB.CN) is 12.47. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLAB.CN's latest enterprise value is 14.56 mil CAD. BLAB.CN's TTM EBITDA according to its financial statements is 1.17 mil CAD. Dividing these 2 quantities gives us the above BLAB.CN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 12.5x | 12.5x |
| Forward P/E multiples | 12.5x - 12.5x | 12.5x |
| Fair Price | 0.06 - 0.06 | 0.06 |
| Upside | 0.4% - 0.4% | 0.4% |
| Date | EV/EBITDA |
| 2024-11-20 | 10.50 |
| 2024-11-19 | 10.50 |
| 2024-11-18 | 11.81 |
| 2024-11-15 | 9.20 |
| 2024-11-12 | 10.50 |
| 2024-11-08 | 11.81 |
| 2024-11-05 | 10.50 |
| 2024-11-04 | 10.50 |
| 2024-11-01 | 10.50 |
| 2024-10-30 | 11.81 |
| 2024-10-29 | 11.81 |
| 2024-10-28 | 11.81 |
| 2024-10-22 | 12.47 |
| 2024-10-21 | 18.36 |
| 2024-10-18 | 13.12 |
| 2024-10-17 | 13.12 |
| 2024-10-09 | 13.78 |
| 2024-10-08 | 13.12 |
| 2024-10-07 | 14.43 |
| 2024-10-04 | 13.12 |
| 2024-10-03 | 16.40 |
| 2024-10-01 | 13.12 |
| 2024-09-27 | 13.12 |
| 2024-09-26 | 13.12 |
| 2024-09-25 | 13.12 |
| 2024-09-23 | 13.12 |
| 2024-09-20 | 13.12 |
| 2024-09-19 | 13.12 |
| 2024-09-18 | 10.50 |
| 2024-09-17 | 13.12 |
| 2024-09-16 | 13.12 |